<DOC>
	<DOCNO>NCT01102504</DOCNO>
	<brief_summary>Stroke second lead cause death worldwide . One cause stroke treat narrow carotid artery . Currently definite treatment option surgery endovascular treatment . All patient qualify await surgery , therefore , leave best medical therapy yearly risk stroke anywhere 1 % - 35 % depend severity disease . The study use property tomato extract contain lycopene . Previously study demonstrate beneficial property tomato extract : 1 . It decrease lipid oxidation 2 . It decrease DNA damage 3 . It property reduce speed amount cell division inflammatory smooth muscle cell undergo ( cell type contribute atheroma formation ) . The investigator wish ass whether long-term food supplementation tomato extract contain lycopene could influence atherosclerotic plaque characteristic . The investigator assess use Magnetic Resonance Imaging plaque transcranial Doppler ultrasonography count number blood clot go brain 's artery . Furthermore investigator wish examine effect long-term food supplementation tomato extract contain lycopene blood cholesterol level lipid oxidation blood marker inflammation injury inner line artery . This single center , double blind , randomise , placebo control study .</brief_summary>
	<brief_title>Supplementation Lycopene Carotid Atheroma</brief_title>
	<detailed_description />
	<mesh_term>Plaque , Atherosclerotic</mesh_term>
	<mesh_term>Carotid Artery Diseases</mesh_term>
	<mesh_term>Lycopene</mesh_term>
	<criteria>Age 40 90 year old , Clinically document carotid symptomatic atherosclerotic disease ( symptomatic disease consider one follow occur within 2 month prior symptom : 1 . Amaurosis fugax 2 . Transient ischemic attack ( TIA ) 3 . Stroke ( ipsilaterally stenotic artery ) &gt; 30 % stenosis initial Bmode ultrasonography imaging , Written , inform consent . Age &lt; 40 year old &gt; 90 year old , Time symptom recruitment &gt; 2 month &lt; 30 % stenosis Bmode ultrasonography imaging , Scheduled surgical/endovascular intervention within 3 month , Highdose statin therapy ( &gt; 80 mg/day fluvastatin ; &gt; 40 mg/day simvastatin ; &gt; 40 mg/day pravastatin ; &gt; 10 mg/day atorvastatin ; &gt; 10 mg/day rosuvastatin 21 ) , Other lipidlowering therapy ( fibric acid derivative , niacin â‰¥250 mg/day , resin , ezetimibe , fishoil supplement ) , Chronic use high dose aspirin &gt; 325 mg/day , Allergy hypersensitivity tomato tomato product , gadolinium history significant atopy/allergy ( e.g . soy , whey , lutein , lecithin ) , Contraindications MRI study include claustrophobia , MRI noncompatible device implant ( vascular clip , metal suture , craniofix , cardiac pacer , endovascular stents/coils , etc . ) , Known renal impairment creatinine clearance &lt; 50 ml/min ( per departmental policy ) , Women childbearing potential , Inability consent</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>carotid atheroma</keyword>
	<keyword>plaque vulnerability</keyword>
	<keyword>stroke risk</keyword>
</DOC>